BridgeMD
Tests treatment safety and results for Schizophrenia
Official title A Study to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japanese Adult Participants With Schizophrenia
ClinicalTrials.gov ID: NCT06882785
What this study is testing
What is KarXT?
KarXT is an investigational medicine, being studied as a potential treatment for schizophrenia.
Also referred to as BMS-986510.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of this study is to evaluate the efficacy and safety of KarXT in acutely psychotic Japanese adult participants with schizophrenia
- Phase 3: a large, late-stage study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Participants must have a primary diagnosis of schizophrenia established by a comprehensive psychiatric evaluation based on the Diagnostic and...
- Participants must have a PANSS total score between 80 and 120, inclusive.
- Participants must have a CGI-S score of ≥ 4.
You likely can't join if
- Participants must not have any primary DSM-5 disorder other than schizophrenia within 12 months before screening.
- Participants must not be newly diagnosed or experiencing their first treated episode of schizophrenia.
- Participants must not have any history or presence of clinically significant medical conditions.
- Other protocol-defined Inclusion/Exclusion criteria apply.
The study team makes the final eligibility decision.
Where it's taking place
- Kōnan, Aichi-ken, Japan
- Nagoya, Aichi-ken, Japan
- Toyoake, Aichi-ken, Japan
- Ichikawa, Chiba, Japan
- MIdori-ku, Chiba-shi, Chiba, Japan
- Iizuka, Fukuoka, Japan
- Kitakyushu, Fukuoka, Japan
- Omuta, Fukuoka, Japan
- Aizu-Wakamatsu, Fukushima, Japan
- Toki, Gifu, Japan
- Kure, Hiroshima, Japan
- Sapporo, Hokkaido, Japan
- Hadano-shi, Kanagawa, Japan
- Hiratsuka, Kanagawa, Japan
- Sagamihara, Kanagawa, Japan
- Yokohama, Kanagawa, Japan
- Kumamoto, Kumamoto, Japan
- Yatsushiro, Kumamoto, Japan
- Maizuru, Kyoto, Japan
- Miyakonojō, Miyazaki, Japan
+ 31 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kōnan, Aichi-ken, Japan; Nagoya, Aichi-ken, Japan; Toyoake, Aichi-ken, Japan; Ichikawa, Chiba, Japan; MIdori-ku, Chiba-shi, Chiba, Japan; Iizuka, Fukuoka, Japan and 45 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.